Abstract

Hypertension induces vascular hypertrophy, which changes blood vessels structurally and functionally, leading to reduced tissue perfusion and further hypertension. It is also associated with dysregulated levels of the circulating adipokines leptin and adiponectin (APN). Leptin is an obesity-associated hormone that promotes vascular smooth muscle cell (VSMC) hypertrophy. APN is a cardioprotective hormone that has been shown to attenuate hypertrophic cardiomyopathy. In this study, we investigated the molecular mechanisms of hypertension-induced VSMC remodeling and the involvement of leptin and APN in this process. To mimic hypertension, the rat portal vein (RPV) was mechanically stretched, and the protective effects of APN on mechanical stretch-induced vascular remodeling and the molecular mechanisms involved were examined by using 10 μg/ml APN. Mechanically stretching the RPV significantly decreased APN protein expression after 24 hours and APN mRNA expression in a time-dependent manner in VSMCs. The mRNA expression of the APN receptors AdipoR1, AdipoR2, and T-cadherin significantly increased after 15 hours of stretch. The ratio of APN/leptin expression in VSMCs significantly decreased after 24 hours of mechanical stretch. Stretching the RPV for 3 days increased the weight and [3H]-leucine incorporation significantly, whereas APN significantly reduced hypertrophy in mechanically stretched vessels. Stretching the RPV for 10 minutes significantly decreased phosphorylation of LKB1, AMPK, and eNOS, while APN significantly increased p-LKB1, p-AMPK, and p-eNOS in stretched vessels. Mechanical stretch significantly increased p-ERK1/2 after 10 minutes, whereas APN significantly reduced stretch-induced ERK1/2 phosphorylation. Stretching the RPV also significantly increased ROS generation after 1 hour, whereas APN significantly decreased mechanical stretch-induced ROS production. Exogenous leptin (3.1 nM) markedly increased GATA-4 nuclear translocation in VSMCs, whereas APN significantly attenuated leptin-induced GATA-4 nuclear translocation. Our results decipher molecular mechanisms of APN-induced attenuation of mechanical stretch-mediated vascular hypertrophy, with the promising potential of ultimately translating this protective hormone into the clinic.

Highlights

  • Being a disease itself, hypertension is a major risk factor for the development of other cardiovascular diseases, such as stroke, renal disease, and heart failure [1, 2]

  • Using real-time PCR analysis, we examined the mRNA expression of the APN receptors AdipoR1, AdipoR2, and T-cadherin and found that they are all expressed in vascular smooth muscle cell (VSMC)

  • The ratio of circulating APN/leptin is emerging as a marker for metabolic syndrome [65, 66], which includes hypertension, and our results indicate that VSMCs can be viewed as contributors to this change in ratio

Read more

Summary

Introduction

Hypertension is a major risk factor for the development of other cardiovascular diseases, such as stroke, renal disease, and heart failure [1, 2]. Oxidative Medicine and Cellular Longevity patients [6,7,8]. After their discovery and for a while, these adipokines were believed to be almost exclusively produced by adipocytes [9,10,11,12,13,14,15], but studies later showed that they are produced by other kinds of cells, including cardiomyocytes [16,17,18]. Little research has been done on whether leptin and APN are produced by VSMCs and whether their expression is affected by hypertension

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call